Filing Flows › Centene (CNC) › Q3 2026 › vs Q2 2026
Centene (CNC) Q3 2026 vs Q2 2026 (quarter over quarter)
Centene's revenue fell $2.9B (-5%) from $53.6B in Q2 2026 to $50.6B in Q3 2026. The biggest changes: Medicaid −$2.4B (-7%); Commercial −$656M (-7%); Medicare +$206M (+2%).
Centene, Q3 2026: revenue $50.6B (+2% year over year), operating margin -0.6%, net loss $65.0M, operating cash flow −$3.7B. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Medicaid | $29.6B | $32.0B | −$2.4B | -7% |
| Medicare | $11.3B | $11.1B | $206M | +2% |
| Commercial | $8.7B | $9.4B | −$656M | -7% |
| Other | $1.1B | $1.2B | −$93.0M | -8% |
| Revenue | $50.6B | $53.6B | −$2.9B | -5% |
| Other income, net | $185M | $288M | −$103M | -36% |
| Income tax benefit | $57.0M | −$399M | $456M | — |
| Net loss | $65.0M | −$1.1B | $1.2B | — |
| Costs & expenses | $51.0B | $53.9B | −$2.9B | -5% |
| Operating costs | $51.0B | $52.4B | −$1.4B | -3% |
| Cost of revenue | $47.3B | $49.0B | −$1.6B | -3% |
| SG&A | $3.2B | $3.1B | $132M | +4% |
| Other operating costs | $374M | $316M | $58.0M | +18% |
| Operating cash sources | $4.0B | −$3.2B | $7.3B | — |
| Depreciation & amortization | $299M | $300M | −$1.0M | -0.3% |
| Share-based compensation | $52.0M | $59.0M | −$7.0M | -12% |
| Cash used in operations | $3.7B | −$3.6B | $7.3B | — |
| Net loss absorbed | $65.0M | −$1.1B | $1.2B | — |
| Working capital & other | $4.0B | −$2.1B | $6.1B | — |
Questions
How much did Centene's revenue grow quarter over quarter in Q3 2026?
Centene's revenue fell $2.9B (-5%) from $53.6B in Q2 2026 to $50.6B in Q3 2026.
What drove Centene's revenue change in Q3 2026?
Medicaid −$2.4B (-7%); Commercial −$656M (-7%); Medicare +$206M (+2%).